re:Invent Amazon has introduced a new generation of SageMaker at the re:Invent conference in Las Vegas, bringing together analytics and AI, though with some confusion thanks to the variety of ...

MSK plans to speed up early-stage drug development by using AWS Drug Discovery Workbench to screen potential candidates.

Is Amazon's (NASDAQ: AMZN) remarkable growth story fizzling? At the low end of this range, that would be the lowest year-over ...

From Amazon Q and SageMaker to customer buying trends in 2024, Amazon CEO Andy Jassy explains why AI has already generated “a multibillion-dollar revenue run rate” for his company. Amazon CEO ...

The expected $100 billion annual capex, up from $83 billion last year, also includes e-commerce warehouses and offices.

Amazon isn't going to allow its arch rivals to dominate the headlines for AI investment. AWS's massive scale and highly ...

Shares of Amazon (NASDAQ: AMZN) slipped as investors were disappointed with the company's first-quarter revenue forecast.

While at AWS, Saha led the creation of one of the fastest-growing AWS businesses and helped to build the multibillion-dollar generative AI business for AWS through products like Amazon SageMaker ...

Amazon (AMZN) is going all-in on artificial intelligence, planning to pour over $100 billion into AI infrastructure in 2025.

Amazon CEO Andy Jassy has expressed his admiration for Chinese AI startup DeepSeek, specifically praising its innovative ...

Amazon’s net sales increased 10% to $187.8 billion in the fourth quarter, compared with $170 billion in the prior year period ...